S. Barnett

Statistics

Publications

Citations

H-Index

Active since

1995

Affiliations

S. Barnett is an author at AstraZeneca (United Kingdom) specializing in pharmacokinetics of anticancer agents, therapeutic tyrosine kinase inhibitors, and cancer cell proliferation inhibition.

Publications per year

1995–2006

Publications

Minimal contribution of desmethyl-gefitinib, the major human plasma metabolite of gefitinib, to epidermal growth factor receptor (EGFR)-mediated tumour growth inhibition

D. McKillop, Simon P. Guy, Mike P. Spence et al. · Xenobiotica · 2006 · 25 citations

Medicine, Oncology, Pharmacology +13

Efficacy of lufenuron against developmental stages of fleas (Ctenocephalides felis felis) in dogs housed in simulated home environments

Byron L. Blagbum, Charles Μ. Hendrix, Joy L. Vaughan et al. · American Journal of Veterinary Research · 1995 · 25 citations · Full text

Veterinary Medicine, Animal Sciences, Veterinary Pharmacology +7

1–2 of 2